AIR LIQUIDE Air Liquide is expanding its home healthcare business in Europe with the acquisition of Baywater Healthcare Ireland Limited, a major player in this activity in Ireland.
On the Irish market for 30 years, Baywater Healthcare Ireland Limited specializes in treating and monitoring respiratory diseases in the patient's home (oxygen therapy, continuous positive airway pressure and non-invasive ventilation). Baywater Healthcare Ireland Limited has 50 employees and cares for 10,000 patients, generating revenue of more than €12 million in 2014.
This acquisition marks a new geographical development for Air Liquide's home healthcare business, with the extension of its services to Ireland. Air Liquide will continue growing the company with the support of the existing team.
Pascal Vinet, Vice-President, Healthcare Global Operations and member of Air Liquide group's Executive Committee commented: "The acquisition of this company, which is recognized for its expertise in the treatment of respiratory diseases and for its culture of innovation, is part of Air Liquide's growth strategy for the home healthcare business. It will allow us to develop on a new growth market in Europe."
supplies medical gases, home healthcare services, hygiene products, medical equipment and specialty ingredients.
In 2014, it served over 7,500 hospitals and 1,2 million patients at home throughout the world.
The Group's Healthcare business reached € 2,570 million in revenues in 2014, with the support of its 12,000 employees.
Air Liquide, European leader in home healthcare, provides home healthcare services in compliance with medical prescription for patients suffering from chronic diseases such as COPD (Chronic Obstructive Pulmonary Disease), sleep apnea and diabetes. These home healthcare services are being developed in addition to hospital care, enabling patients to enjoy better quality of life and local authorities to reduce costs. Home healthcare represents 50% of Air Liquide's revenue in Healthcare in 2014.
|
distributed by
|
